New Investigator and Trainee Telementoring Seminar Series: Navigating Relationships with Industry by Sheena Aurora, MD, FAHS
About Dr. Aurora
Sheena K. Aurora, M.D. is a Medical Fellow, Global Launch Leaders at Eli Lilly. Prior to her position at Eli Lilly she was a Clinical Associate Professor, Neurology at Stanford University’s School of Medicine. Dr. Aurora’s focus is on novel treatments for migraine and other primary headache disorders. A national leader in headache research and treatment, she was the lead investigator for the PREEMPT1 trial which led to the FDA approval of BOTOX® to treat chronic migraine, and has participated in six additional clinical trials and studies. A graduate of Christian Medical College, Dr. Aurora attended Henry Ford Hospital where she studied Neurology. She then served as Director of the Headache Clinic at Henry Ford Hospital for four years before becoming Co-Director of the Swedish Headache Center at the Swedish Neuroscience Institute in Seattle, Washington. From 2001-2012, Dr. Aurora served as an Assistant Professor in the Department of Neurology at the University of Washington in Seattle. Dr. Aurora was voted as one of the best doctors in Seattle Magazine’s “Seattle Best Doctors” in 2010 and 2011. Dr. Aurora currently serves in five professional societies, including: NIH Headache Research Planning, American Academy of Neurology, Migraine Research Foundation Medical Advisory Board, NINDS Common Data Elements, and the American Headache Society.
Resources Items for Download:
- Download recording here